Ragosa Mark
Insider CIK 1835458 · KNSA Interim CFO
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| KNSA Kiniksa Pharmaceuticals In | M Exercise deriv | 2026-09-01 | 2026-09-03 | 1,750 | — | $0 | 1,750 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise deriv | 2026-09-01 | 2026-09-03 | 1,591 | — | $0 | 3,182 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | A Award deriv | 2026-09-01 | 2026-09-03 | 7,800 | — | $0 | 7,800 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | A Award deriv | 2026-09-01 | 2026-09-03 | 31,150 | — | $0 | 31,150 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise deriv | 2026-09-01 | 2026-09-03 | 2,694 | — | $0 | 0 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise deriv | 2026-09-01 | 2026-09-03 | 3,069 | — | $0 | 9,206 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise | 2026-09-01 | 2026-09-03 | 1,591 | — | $0 | 22,189 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise | 2026-09-01 | 2026-09-03 | 3,069 | — | $0 | 25,258 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | F Tax w/h | 2026-09-01 | 2026-09-03 | 4,404 | $79.28 | $349.1K | 20,854 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise | 2026-09-01 | 2026-09-03 | 1,750 | — | $0 | 20,598 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise | 2026-09-01 | 2026-09-03 | 2,694 | — | $0 | 18,848 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise deriv | 2026-09-01 | 2026-09-03 | 2,694 | — | $0 | 0 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise deriv | 2026-09-01 | 2026-09-03 | 1,750 | — | $0 | 1,750 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise deriv | 2026-09-01 | 2026-09-03 | 1,591 | — | $0 | 3,182 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise deriv | 2026-09-01 | 2026-09-03 | 3,069 | — | $0 | 9,206 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | A Award deriv | 2026-09-01 | 2026-09-03 | 31,150 | — | $0 | 31,150 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | A Award deriv | 2026-09-01 | 2026-09-03 | 7,800 | — | $0 | 7,800 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | F Tax w/h | 2026-09-01 | 2026-09-03 | 4,404 | $79.28 | $349.1K | 20,854 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise | 2026-09-01 | 2026-09-03 | 3,069 | — | — | 25,258 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise | 2026-09-01 | 2026-09-03 | 1,591 | — | — | 22,189 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise | 2026-09-01 | 2026-09-03 | 1,750 | — | — | 20,598 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise | 2026-09-01 | 2026-09-03 | 2,694 | — | — | 18,848 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise deriv | 2026-04-07 | 2026-04-08 | 2,694 | — | $0 | 0 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | F Tax w/h | 2026-04-07 | 2026-04-08 | 1,303 | $48.94 | $63.8K | 16,154 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise | 2026-04-07 | 2026-04-08 | 2,694 | — | $0 | 17,457 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise deriv | 2026-04-01 | 2026-04-03 | 1,591 | — | $0 | 3,182 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise deriv | 2026-04-01 | 2026-04-03 | 1,750 | — | $0 | 1,750 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | A Award deriv | 2026-04-01 | 2026-04-03 | 15,600 | — | $0 | 15,600 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise deriv | 2026-04-01 | 2026-04-03 | 1,846 | — | $0 | 5,536 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | A Award deriv | 2026-04-01 | 2026-04-03 | 31,150 | — | $0 | 31,150 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | A Award deriv | 2026-04-01 | 2026-04-03 | 7,800 | — | $0 | 7,800 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise | 2026-04-01 | 2026-04-03 | 5,187 | — | $0 | 17,273 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | F Tax w/h | 2026-04-01 | 2026-04-03 | 2,510 | $48.13 | $120.8K | 14,763 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise deriv | 2026-03-09 | 2026-03-11 | 10,513 | — | $0 | 18,396 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise deriv | 2026-03-09 | 2026-03-11 | 13,813 | — | $0 | 19,337 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise deriv | 2026-03-09 | 2026-03-11 | 10,360 | — | $0 | 22,790 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise deriv | 2026-03-09 | 2026-03-11 | 2,036 | — | $0 | 0 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | S Sale | 2026-03-09 | 2026-03-11 | 17,981 | $45.58 | $819.6K | 30,827 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | S Sale | 2026-03-09 | 2026-03-11 | 18,741 | $46.24 | $866.6K | 12,086 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise | 2026-03-09 | 2026-03-11 | 10,360 | $26.74 | $277.0K | 48,808 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise | 2026-03-09 | 2026-03-11 | 13,813 | $18.06 | $249.5K | 38,448 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise | 2026-03-09 | 2026-03-11 | 10,513 | $17.76 | $186.7K | 24,635 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise | 2026-03-09 | 2026-03-11 | 2,036 | $22.89 | $46.6K | 14,122 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise deriv | 2026-02-09 | 2026-02-11 | 8,374 | — | $0 | 0 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise deriv | 2026-02-09 | 2026-02-11 | 2,471 | — | $0 | 0 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise | 2026-02-09 | 2026-02-11 | 8,374 | $12.97 | $108.6K | 27,460 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise | 2026-02-09 | 2026-02-11 | 2,471 | $16.90 | $41.8K | 29,931 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | S Sale | 2026-02-09 | 2026-02-11 | 8,731 | $43.72 | $381.7K | 12,086 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | S Sale | 2026-02-09 | 2026-02-11 | 9,114 | $42.85 | $390.5K | 20,817 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | S Sale | 2026-01-08 | 2026-01-09 | 12,000 | $41.89 | $502.7K | 19,086 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise deriv | 2025-12-08 | 2025-12-10 | 16,164 | — | $0 | 5,388 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise deriv | 2025-12-08 | 2025-12-10 | 10,512 | — | $0 | 14,016 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise deriv | 2025-12-08 | 2025-12-10 | 16,165 | — | $0 | 12,123 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | S Sale | 2025-12-08 | 2025-12-10 | 42,841 | $41.49 | $1.78M | 31,086 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise | 2025-12-08 | 2025-12-10 | 16,164 | $11.10 | $179.4K | 47,250 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise | 2025-12-08 | 2025-12-10 | 16,165 | $11.97 | $193.5K | 63,415 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise | 2025-12-08 | 2025-12-10 | 10,512 | $10.76 | $113.1K | 73,927 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise deriv | 2025-11-12 | 2025-11-14 | 19,900 | — | $0 | 0 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | S Sale | 2025-11-12 | 2025-11-14 | 19,900 | $40.94 | $814.7K | 31,086 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise | 2025-11-12 | 2025-11-14 | 19,900 | $30.93 | $615.5K | 50,986 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise deriv | 2025-10-28 | 2025-10-30 | 100 | — | $0 | 19,900 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | S Sale | 2025-10-28 | 2025-10-30 | 100 | $41.00 | $4.1K | 31,086 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise | 2025-10-28 | 2025-10-30 | 100 | $30.93 | $3.1K | 31,186 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise deriv | 2025-09-02 | 2025-09-03 | 1,861 | — | $0 | 0 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | F Tax w/h | 2025-09-02 | 2025-09-03 | 900 | $34.28 | $30.9K | 31,086 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise | 2025-09-02 | 2025-09-03 | 1,861 | — | $0 | 31,986 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise deriv | 2025-09-01 | 2025-09-03 | 1,592 | — | $0 | 4,773 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise deriv | 2025-09-01 | 2025-09-03 | 2,694 | — | $0 | 2,694 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise deriv | 2025-09-01 | 2025-09-03 | 1,750 | — | $0 | 3,500 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | A Award deriv | 2025-09-01 | 2025-09-03 | 39,363 | — | $0 | 39,363 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | A Award deriv | 2025-09-01 | 2025-09-03 | 12,275 | — | $0 | 12,275 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | F Tax w/h | 2025-09-01 | 2025-09-03 | 2,920 | $33.49 | $97.8K | 30,125 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise | 2025-09-01 | 2025-09-03 | 2,694 | — | $0 | 33,045 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise | 2025-09-01 | 2025-09-03 | 1,750 | — | $0 | 30,351 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise | 2025-09-01 | 2025-09-03 | 1,592 | — | $0 | 28,601 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise deriv | 2025-08-04 | 2025-08-06 | 18,889 | — | $0 | 2,036 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | S Sale | 2025-08-04 | 2025-08-06 | 18,889 | $32.89 | $621.3K | 27,009 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise | 2025-08-04 | 2025-08-06 | 18,889 | $22.89 | $432.4K | 45,898 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise deriv | 2025-06-03 | 2025-06-05 | 18,299 | — | $0 | 0 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise | 2025-06-03 | 2025-06-05 | 18,299 | $18.00 | $329.4K | 45,308 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | S Sale | 2025-06-03 | 2025-06-05 | 18,299 | $28.80 | $527.0K | 27,009 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise deriv | 2025-05-01 | 2025-05-01 | 12,000 | — | $0 | 0 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise deriv | 2025-05-01 | 2025-05-01 | 13,141 | — | $0 | 28,909 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | A Award deriv | 2025-05-01 | 2025-05-05 | 4,786 | — | $0 | 4,876 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | A Award deriv | 2025-05-01 | 2025-05-05 | 7,368 | — | $0 | 7,368 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | A Award deriv | 2025-05-01 | 2025-05-05 | 7,606 | — | $0 | 7,606 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | A Award deriv | 2025-05-01 | 2025-05-05 | 4,558 | — | $0 | 4,558 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | S Sale | 2025-05-01 | 2025-05-01 | 25,141 | $27.80 | $698.9K | 27,009 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise | 2025-05-01 | 2025-05-01 | 12,000 | $17.92 | $215.0K | 39,009 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise | 2025-05-01 | 2025-05-01 | 13,141 | $17.76 | $233.4K | 52,150 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise deriv | 2025-04-30 | 2025-05-01 | 21,254 | — | $0 | 2,471 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise | 2025-04-30 | 2025-05-01 | 21,254 | $16.90 | $359.2K | 48,263 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | S Sale | 2025-04-30 | 2025-05-01 | 21,254 | $26.95 | $572.8K | 27,009 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise deriv | 2025-04-29 | 2025-05-01 | 20,000 | — | $0 | 0 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise deriv | 2025-04-29 | 2025-05-01 | 22,000 | — | $0 | 0 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise | 2025-04-29 | 2025-05-01 | 20,000 | $15.52 | $310.4K | 47,009 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise | 2025-04-29 | 2025-05-01 | 22,000 | $15.50 | $341.0K | 69,009 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | S Sale | 2025-04-29 | 2025-05-01 | 42,000 | $25.61 | $1.08M | 27,009 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise deriv | 2025-04-26 | 2025-04-29 | 990 | — | $0 | 0 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise | 2025-04-26 | 2025-04-29 | 990 | — | $0 | 27,488 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | F Tax w/h | 2025-04-26 | 2025-04-29 | 479 | $21.37 | $10.2K | 27,009 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise deriv | 2025-04-07 | 2025-04-09 | 2,694 | — | $0 | 2,694 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | F Tax w/h | 2025-04-07 | 2025-04-09 | 1,303 | $20.28 | $26.4K | 26,498 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise | 2025-04-07 | 2025-04-09 | 2,694 | — | $0 | 27,801 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise deriv | 2025-04-01 | 2025-04-03 | 1,750 | — | $0 | 3,500 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | A Award deriv | 2025-04-01 | 2025-04-03 | 29,480 | — | $0 | 29,480 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | A Award deriv | 2025-04-01 | 2025-04-03 | 7,382 | — | $0 | 7,382 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise deriv | 2025-04-01 | 2025-04-03 | 1,592 | — | $0 | 4,773 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | A Award deriv | 2025-04-01 | 2025-04-03 | 14,765 | — | $0 | 14,765 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | F Tax w/h | 2025-04-01 | 2025-04-03 | 847 | $21.77 | $18.4K | 25,877 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise | 2025-04-01 | 2025-04-03 | 1,750 | — | $0 | 25,132 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise | 2025-04-01 | 2025-04-03 | 1,592 | — | $0 | 26,724 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | F Tax w/h | 2025-04-01 | 2025-04-03 | 770 | $21.77 | $16.8K | 25,107 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise deriv | 2025-03-20 | 2025-03-24 | 15,944 | — | $0 | 8,374 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | S Sale | 2025-03-20 | 2025-03-24 | 15,944 | $23.11 | $368.5K | 23,382 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise | 2025-03-20 | 2025-03-24 | 15,944 | $12.97 | $206.8K | 39,326 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise deriv | 2025-03-19 | 2025-03-19 | 8,879 | — | $0 | 24,318 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise | 2025-03-19 | 2025-03-19 | 8,879 | $12.97 | $115.2K | 32,261 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | S Sale | 2025-03-19 | 2025-03-19 | 8,879 | $23.10 | $205.1K | 23,382 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise deriv | 2025-03-17 | 2025-03-19 | 11,464 | — | $0 | 33,197 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise | 2025-03-17 | 2025-03-19 | 11,464 | $12.97 | $148.7K | 34,846 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | S Sale | 2025-03-17 | 2025-03-19 | 11,464 | $23.10 | $264.8K | 23,382 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise deriv | 2025-03-16 | 2025-03-19 | 872 | — | $0 | 0 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | F Tax w/h | 2025-03-16 | 2025-03-19 | 448 | $22.61 | $10.1K | 23,382 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise | 2025-03-16 | 2025-03-19 | 872 | — | $0 | 23,830 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise deriv | 2025-03-12 | 2025-03-14 | 36,372 | — | $0 | 28,288 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise | 2025-03-12 | 2025-03-14 | 36,372 | $11.97 | $435.4K | 59,330 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | S Sale | 2025-03-12 | 2025-03-14 | 36,372 | $22.25 | $809.3K | 22,958 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise deriv | 2024-12-09 | 2024-12-10 | 18,860 | — | $0 | 21,552 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | S Sale | 2024-12-09 | 2024-12-10 | 18,860 | $21.38 | $403.2K | 22,958 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise | 2024-12-09 | 2024-12-10 | 18,860 | $11.10 | $209.3K | 41,818 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise deriv | 2024-12-06 | 2024-12-10 | 2,406 | — | $0 | 24,528 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | S Sale | 2024-12-06 | 2024-12-10 | 8,969 | $21.27 | $190.8K | 22,958 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise | 2024-12-06 | 2024-12-10 | 2,406 | $10.76 | $25.9K | 25,364 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise deriv | 2024-12-05 | 2024-12-05 | 1,123 | — | $0 | 26,934 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise | 2024-12-05 | 2024-12-05 | 1,123 | $10.76 | $12.1K | 24,081 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | S Sale | 2024-12-05 | 2024-12-05 | 1,123 | $21.25 | $23.9K | 22,958 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise deriv | 2024-12-04 | 2024-12-05 | 5,024 | — | $0 | 28,057 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | S Sale | 2024-12-04 | 2024-12-05 | 5,024 | $21.25 | $106.8K | 22,958 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise | 2024-12-04 | 2024-12-05 | 5,024 | $10.76 | $54.1K | 27,982 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise deriv | 2024-12-03 | 2024-12-05 | 8,969 | — | $0 | 33,081 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | S Sale | 2024-12-03 | 2024-12-05 | 8,969 | $21.45 | $192.4K | 22,958 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise | 2024-12-03 | 2024-12-05 | 8,969 | $10.76 | $96.5K | 31,927 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise deriv | 2024-09-02 | 2024-09-04 | 1,861 | — | $0 | 1,861 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise | 2024-09-02 | 2024-09-04 | 1,861 | — | $0 | 23,914 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | F Tax w/h | 2024-09-02 | 2024-09-04 | 956 | $26.74 | $25.6K | 22,958 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise deriv | 2024-09-01 | 2024-09-04 | 1,750 | — | $0 | 5,250 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise deriv | 2024-09-01 | 2024-09-04 | 2,694 | — | $0 | 5,388 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | A Award deriv | 2024-09-01 | 2024-09-04 | 33,150 | — | $0 | 33,150 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | A Award deriv | 2024-09-01 | 2024-09-04 | 6,365 | — | $0 | 6,365 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise | 2024-09-01 | 2024-09-04 | 4,444 | — | $0 | 24,313 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | F Tax w/h | 2024-09-01 | 2024-09-04 | 2,260 | $26.74 | $60.4K | 22,053 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise deriv | 2024-07-23 | 2024-07-25 | 24,248 | — | $0 | 40,412 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | S Sale | 2024-07-23 | 2024-07-25 | 24,248 | $24.79 | $601.1K | 19,253 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise | 2024-07-23 | 2024-07-25 | 24,248 | $11.10 | $269.2K | 43,501 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | M Exercise deriv | 2024-04-26 | 2024-04-30 | 991 | — | $0 | 990 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | M Exercise | 2024-04-26 | 2024-04-30 | 991 | — | $0 | 19,762 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | F Tax w/h | 2024-04-26 | 2024-04-30 | 509 | $17.88 | $9.1K | 19,253 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | M Exercise deriv | 2024-04-08 | 2024-04-08 | 2,694 | — | $0 | 8,921 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | M Exercise | 2024-04-08 | 2024-04-08 | 2,694 | — | $0 | 19,562 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | F Tax w/h | 2024-04-08 | 2024-04-08 | 791 | $17.90 | $14.2K | 18,771 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | A Award deriv | 2024-04-04 | 2024-04-08 | 6,365 | — | $0 | 11,615 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | A Award deriv | 2024-04-04 | 2024-04-08 | 5,092 | — | $0 | 5,092 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | A Award deriv | 2024-04-04 | 2024-04-08 | 33,150 | — | $0 | 33,150 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | M Exercise deriv | 2024-04-01 | 2024-04-03 | 1,750 | — | $0 | 5,250 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | F Tax w/h | 2024-04-01 | 2024-04-03 | 514 | $19.70 | $10.1K | 16,868 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | M Exercise | 2024-04-01 | 2024-04-03 | 1,750 | — | $0 | 17,382 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | M Exercise deriv | 2024-01-03 | 2024-01-04 | 12,000 | — | $0 | 0 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | S Sale | 2024-01-03 | 2024-01-04 | 12,000 | $20.00 | $240.0K | 15,632 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | M Exercise | 2024-01-03 | 2024-01-04 | 12,000 | $8.83 | $106.0K | 27,632 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | M Exercise deriv | 2023-09-02 | 2023-09-06 | 1,861 | — | $0 | 3,722 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | M Exercise | 2023-09-02 | 2023-09-06 | 1,861 | — | $0 | 16,179 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | F Tax w/h | 2023-09-02 | 2023-09-06 | 547 | $17.76 | $9.7K | 15,632 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | A Award deriv | 2023-09-01 | 2023-09-06 | 7,000 | — | $0 | 7,000 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | A Award deriv | 2023-09-01 | 2023-09-06 | 42,050 | — | $0 | 42,050 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | M Exercise deriv | 2023-09-01 | 2023-09-06 | 2,695 | — | $0 | 8,082 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | M Exercise | 2023-09-01 | 2023-09-06 | 2,695 | — | $0 | 15,109 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | F Tax w/h | 2023-09-01 | 2023-09-06 | 791 | $17.76 | $14.0K | 14,318 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | M Exercise deriv | 2023-04-26 | 2023-04-28 | 990 | — | $0 | 1,981 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | M Exercise | 2023-04-26 | 2023-04-28 | 990 | — | $0 | 12,705 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | F Tax w/h | 2023-04-26 | 2023-04-28 | 291 | $11.15 | $3.2K | 12,414 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | M Exercise deriv | 2023-04-10 | 2023-04-11 | 2,695 | — | $0 | 8,082 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | F Tax w/h | 2023-04-10 | 2023-04-11 | 791 | $10.71 | $8.5K | 11,715 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | M Exercise | 2023-04-10 | 2023-04-11 | 2,695 | — | $0 | 12,506 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | A Award deriv | 2023-04-01 | 2023-04-03 | 42,050 | — | $0 | 42,050 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | A Award deriv | 2023-04-01 | 2023-04-03 | 7,000 | — | $0 | 7,000 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | M Exercise deriv | 2023-03-20 | 2023-03-20 | 2,158 | — | $0 | 0 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | M Exercise | 2023-03-20 | 2023-03-20 | 2,158 | — | $0 | 10,445 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | F Tax w/h | 2023-03-20 | 2023-03-20 | 634 | $11.12 | $7.1K | 9,811 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | M Exercise deriv | 2023-03-16 | 2023-03-20 | 872 | — | $0 | 1,744 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | F Tax w/h | 2023-03-16 | 2023-03-20 | 256 | $11.46 | $2.9K | 8,287 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | M Exercise | 2023-03-16 | 2023-03-20 | 872 | — | $0 | 8,543 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | M Exercise deriv | 2022-09-02 | 2022-09-06 | 1,861 | — | $0 | 5,583 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | M Exercise | 2022-09-02 | 2022-09-06 | 1,861 | — | $0 | 8,218 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | F Tax w/h | 2022-09-02 | 2022-09-06 | 547 | $11.44 | $6.3K | 7,671 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | A Award deriv | 2022-09-01 | 2022-09-06 | 64,660 | — | $0 | 64,660 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | A Award deriv | 2022-09-01 | 2022-09-06 | 10,777 | — | $0 | 10,777 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | M Exercise deriv | 2022-04-26 | 2022-04-28 | 991 | — | $0 | 2,971 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | F Tax w/h | 2022-04-26 | 2022-04-28 | 282 | $9.99 | $2.8K | 6,357 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | M Exercise | 2022-04-26 | 2022-04-28 | 991 | — | $0 | 6,639 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | A Award deriv | 2022-04-07 | 2022-04-11 | 64,660 | — | $0 | 64,660 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | A Award deriv | 2022-04-07 | 2022-04-11 | 10,777 | — | $0 | 10,777 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | M Exercise deriv | 2022-03-21 | 2022-03-23 | 3,019 | — | $0 | 0 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | F Tax w/h | 2022-03-21 | 2022-03-23 | 1,047 | $10.98 | $11.5K | 5,648 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | M Exercise | 2022-03-21 | 2022-03-23 | 3,019 | — | $0 | 6,695 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | M Exercise deriv | 2022-03-16 | 2022-03-18 | 872 | — | $0 | 2,616 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | M Exercise | 2022-03-16 | 2022-03-18 | 872 | — | $0 | 3,979 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | F Tax w/h | 2022-03-16 | 2022-03-18 | 303 | $10.13 | $3.1K | 3,676 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | A Award deriv | 2021-09-02 | 2021-09-07 | 44,661 | — | $0 | 44,661 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | A Award deriv | 2021-09-02 | 2021-09-07 | 7,444 | — | $0 | 7,444 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | A Award deriv | 2021-04-26 | 2021-04-28 | 3,962 | — | $0 | 3,962 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | A Award deriv | 2021-04-26 | 2021-04-28 | 23,725 | — | $0 | 23,725 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | A Award deriv | 2021-03-20 | 2021-03-23 | 2,158 | — | $0 | 2,158 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | A Award deriv | 2021-03-20 | 2021-03-23 | 3,019 | — | $0 | 3,019 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | A Award deriv | 2021-03-16 | 2021-03-18 | 3,488 | — | $0 | 3,488 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | A Award deriv | 2021-03-16 | 2021-03-18 | 20,925 | — | $0 | 20,925 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | M Exercise deriv | 2020-12-31 | 2021-01-05 | 4,404 | — | $0 | 0 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | F Tax w/h | 2020-12-31 | 2021-01-05 | 1,297 | $17.67 | $22.9K | 3,107 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | M Exercise | 2020-12-31 | 2021-01-05 | 4,404 | — | $0 | 4,404 | SEC↗ |